A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 45/06 (2006.01) A61K 31/415 (2006.01) A61K 31/42 (2006.01) A61K 31/425 (2006.01) A61K 31/47 (2006.01) A61K 31/495 (2006.01) A61K 31/4985 (2006.01) A61K 31/55 (2006.01) A61K 31/70 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2390317
The invention concerns a product inhibiting transduction of G heterotrimeric protein signals combined with another anti-cancer agent, in particular farnesyltransferase inhibitors, taxol or gemcitabin, for simultaneous, separate or prolonged therapeutic use in cancer treatment.
L'invention concerne un produit comprenant au moins un inhibiteur de la transduction des signaux des protéines G hétérotrimériques, en association avec au moins un autre agent anti-cancéreux, en particulier des inhibiteurs de farnésyltransférases, le taxol ou la gemcitabine, pour une utilisation thérapeutique simultanée, séparée ou étalée dans le temps, dans le traitement du cancer.
Gordon Thomas
Lonchampt Marie-Odile
Morgan Barry
Prevost Gregoire
Goudreau Gage Dubuc
Ipsen Pharma S.a.s
Societe de Conseils de Recherches Et D'applications Scientifique
LandOfFree
Product inhibiting transduction of g heterotrimeric protein... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Product inhibiting transduction of g heterotrimeric protein..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Product inhibiting transduction of g heterotrimeric protein... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1356033